Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2020Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q2 $ vs. 2020Q2
Outlook Therapeutics, Inc. *W EXP 02/18/202 420,875 $54,000 0.00% No Change -$54,000
AGIOS PHARMACEUTICALS, INC. 0 $0 0% Closed -$48,132,000
Akebia Therapeutics, Inc. 0 $0 0% Closed -$716,000
Alector, Inc. 0 $0 0% Closed -$12,507,000
Apellis Pharmaceuticals, Inc. 0 $0 0% Closed -$373,000
AVADEL PHARMACEUTICALS PLC SPONSORED ADR 0 $0 0% Closed -$133,000
Axsome Therapeutics, Inc. 0 $0 0% Closed -$4,114,000
BELLUS Health Inc. 0 $0 0% Closed -$11,576,000
Black Diamond Therapeutics, Inc. 0 $0 0% Closed -$43,996,000
ChemoCentryx, Inc. 0 $0 0% Closed -$590,000
Cue Biopharma, Inc. 0 $0 0% Closed -$646,000
DENALI THERAPEUTICS INC 0 $0 0% Closed -$20,553,000
DermTech, Inc. 0 $0 0% Closed -$6,445,000
DYNAVAX TECHNOLOGIES CORP 0 $0 0% Closed -$1,570,000
ESTABLISHMENT LABS HOLDINGS INC. 0 $0 0% Closed -$13,750,000
Ferrari N.V. 0 $0 0% Closed -$1,060,000
Fulcrum Therapeutics, Inc. 0 $0 0% Closed -$15,768,000
IMMUNOMEDICS INC PUT 0 $0 0% Closed -$3,544,000
Karuna Therapeutics, Inc. 0 $0 0% Closed -$774,000
LUMINEX CORP 0 $0 0% Closed -$616,000
Medtronic plc 0 $0 0% Closed -$1,834,000
Menlo Therapeutics Inc. 0 $0 0% Closed -$39,576,000
Moderna, Inc. PUT 0 $0 0% Closed -$6,421,000
MOMENTA PHARMACEUTICALS INC 0 $0 0% Closed -$1,019,000
Neoleukin Therapeutics, Inc. 0 $0 0% Closed -$8,921,000